Serum Institute of India produces over 10 crore doses of Covishield in June

The Serum Institute of India (SII) has produced over 10 crore doses of AstraZeneca's Covid vaccine - Covishield - in the month of June.

Fulfilling its commitment, Serum Institute of India has produced over 10 crore doses of its Covid-19 vaccine Covishield in June so far as India ramps up the pace of its vaccination drive in the face of a possible third wave of the viral infection. India's Covid-19 inoculation drive has picked up pace under the new phase of universalisation of Covid-19 vaccination that commenced on June 21 with around 69 lakh vaccine doses being administered on an average daily in the last six days.